Shares of medical technology company Inspire Medical Systems (NYSE:INSP) fell 41.3% in the afternoon session after the ...

Inspire Medical stock falls as Q2 earnings beat is overshadowed by guidance cut and slower U.S. rollout of its newly approved ...

Q2 2025 Earnings Call Transcript August 4, 2025 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is $0 ...

Baron Funds, an investment management company, released its “Baron Discovery Fund” second-quarter 2025 investor letter. A ...

Three new studies suggest that Ozempic and related diabetes and weight loss drugs may help protect the brain from strokes.

Kym Whitley partners with Eli Lilly to share her transformative experience using Zepbound, an obesity management medication.

Investing.com -- Inspire Medical Systems (NYSE: INSP) stock plunged 27% after the company’s disappointing quarterly results and guidance prompted four Wall Street firms to downgrade the shares.

A new study in mice shows that tirzepatide—the active ingredient in the popular drugs Mounjaro and Zepbound—not only helps shed pounds but may also slow or reduce the growth of breast cancer tumors ...

Inspire Medical Systems (NYSE:INSP) saw its stock plunge 27% following disappointing quarterly results and a lowered outlook, which led four major Wall Street firms to downgrade the shares. Truist ...

FILE PHOTO: A trader works, as screens broadcast a press conference by U.S. Federal Reserve Chair Jerome Powell following the ...

A HEREFORD woman has lost an incredible six stone after being refused hip surgery due to her BMI. In October 2024, Anne Davies joined the Westfields Slimming World group, "not for vanity but out of ...

He is known as a dad, husband and pastor, but most importantly as Papa to his grandchildren. Joy and faith are the two things ...